Mercer Global Advisors »

Janux Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $195k 13k 15.36

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
Prosight Management
State Street Corporation
FMR
Federated Investors
Point72 Asset Management
Vanguard Capital Management
TCG Crossover Management
Alyeska Investment Group
Wellington Management Company
Vanguard Portfolio Management
Citadel Advisors
Two Sigma Investments

View all funds holding Janux Therapeutics